Skip over navigation
Home
Investment Team
Portfolio
Press Room
Contact
THERAPEUTICS
DIAGNOSTICS
SERVICES and IT
PREVIOUS
Print Portfolio
Rapid point-of-care assay for measuring efficacy of anti-platelet medication
Celula develops innovative instrument systems for esoteric molecular diagnostics using advanced microfluidics technologies
Real-time inpatient glycemic monitoring
A diagnostics company commercializing a novel FDA approved diagnostic for latent tuberculosis
Non-invasive products for informed cancer management
A
mbulatory Cardiac Rhythm Monitoring